Rigel Pharmaceuticals
RIGL
RIGL
133 hedge funds and large institutions have $365M invested in Rigel Pharmaceuticals in 2018 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 50 increasing their positions, 32 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
6% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 16
1% less funds holding
Funds holding: 135 → 133 (-2)
27% less capital invested
Capital invested by funds: $503M → $365M (-$138M)
Holders
133
Holding in Top 10
1
Calls
$1.73M
Puts
$881K
Top Buyers
| 1 | +$4.64M | |
| 2 | +$3.19M | |
| 3 | +$2.68M | |
| 4 |
TA
Tamarack Advisers
Carlsbad,
California
|
+$2.19M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$1.59M |
Top Sellers
| 1 | -$7.45M | |
| 2 | -$6.41M | |
| 3 | -$1.74M | |
| 4 |
BRF
B. Riley Financial
Los Angeles,
California
|
-$1.52M |
| 5 |
MWNA
Marshall Wace North America
New York
|
-$1.17M |